Article
Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics.
Experimental hematology - 1 Sept 2026
Laganà Alessandro, Iaquinta Giovanni, Santopietro Michelina, Luzi Giovanni, Ragazzo Michele, Angeloni Silvia, Cerroni Chiara, Tamburini Anna, Leonetti Crescenzi Sabrina, Tatarelli Caterina, Abruzzese Elisabetta, Trawinska Malgorzata Monika, Paciaroni Katia, Celesti Francesca, Caravita Di Toritto Tommaso, Grammatico Paola, Breccia Massimo
Abstract excerpt
Somatic mutations involving the canonical exon 10 hotspots of the thrombopoietin receptor gene (MPL) are established drivers in myeloproliferative neoplasms (MPNs), whereas the significance of rare, atypical variants remains unclear. We investigated the relevance of three uncommon MPL variants affecting residues Y591 and R592. Among a multicenter cohort of myeloid neoplasms undergoing next-generation sequencing...
Read the complete abstract on PubMedTopics
- Receptors, Thrombopoietin
- Humans
- Myeloproliferative Disorders
